BRAF and cancer: The presence of BRAF T1799A oncogene is an unfavorable prognostic factor in PTC as it increases the aggressive nature of cancer through raising its invasiveness, accelerating relapses and the occurrence of metastases[23,33,34,36,37,42-44] BRAF gene encodes BRAF protein.